Journal article
Impact of genetic variants in IL-4, IL-4 RA and IL-13 on the anti-pneumococcal antibody response
Vaccine, Vol.25(2), pp.306-313
2007
Abstract
Background
Significant differences in immune responses upon vaccination have been described, suggesting genetics are important in determining the magnitude of vaccine responses. The interleukin (IL)-4 pathway, including IL-4, IL-13 and the IL-4 receptor α chain (IL-4 Rα), is central to humoral responses and therefore could have an impact on vaccine responsiveness.
Objective
To investigate whether single nucleotide polymorphisms (SNPs) in the IL-4, IL-13 and IL-4 RA genes influence pneumococcal serotype-specific IgG antibody responses.
Methods
SNPs in the IL-4 gene (C −589T, G2979T), the IL-13 gene (G −1112A, Arg130Gln) and in the IL-4 RA gene (Ile50Val, Gln551Arg) were investigated in isolation and in combination, for their influence on serotype-specific IgG antibody responses upon combined pneumococcal conjugate and polysaccharide vaccinations in children with a history of recurrent otitis media.
Results
Lower antibody responses were observed for alleles previously associated with atopy, IL-4 −589T, IL-4 2979T and IL-4 Rα 551Gln. Effects were stronger in gene haplotype combinations or in multiple haplotype combination analyses.
Conclusion
This study highlights the importance of host genetic factors in vaccine responses. Furthermore, it supports the approach of studying the effect of combinations of multiple alleles, in haplotypes or in combinations of haplotypes, on complex phenotypes within a biological pathway.
Details
- Title
- Impact of genetic variants in IL-4, IL-4 RA and IL-13 on the anti-pneumococcal antibody response
- Authors/Creators
- S.P. Wiertsema (Author/Creator) - Wilhelmina Children's HospitalG. Baynam (Author/Creator) - The University of Western AustraliaS-K Khoo (Author/Creator) - The University of Western AustraliaR.H. Veenhoven (Author/Creator) - Spaarne ZiekenhuisN. van Heerbeek (Author/Creator) - Radboud University Medical CenterG. Zhang (Author/Creator) - The University of Western AustraliaI.A. Laing (Author/Creator) - The University of Western AustraliaG.T. Rijkers (Author/Creator) - Wilhelmina Children's HospitalJ. Goldblatt (Author/Creator) - The University of Western AustraliaE.A.M. Sanders (Author/Creator) - Spaarne ZiekenhuisP.N. Le Souëf (Author/Creator) - The University of Western Australia
- Publication Details
- Vaccine, Vol.25(2), pp.306-313
- Publisher
- Elsevier BV
- Identifiers
- 991005542268307891
- Copyright
- © 2006 Elsevier Ltd
- Murdoch Affiliation
- Murdoch University
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
37 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.23 Antibiotics & Antimicrobials
- 1.23.347 Streptococcus Pneumoniae
- Web Of Science research areas
- Immunology
- Medicine, Research & Experimental
- ESI research areas
- Immunology